(a)
Subgroups
Trial
Patient number
SC dose* (106 )
Followup* (months)
Time to PCI*(hours)
SC delivery Time* (days) BMSC Placebo BMSC Placebo Short term PCI < 6 (hours) EF < 45% Penicka et al., 2007 +++++ [17 ]
113
69 523.4 5.7 5.0 4.9 6.7 Tendera et al., 2009 REGENT [4 ] Piepoli et al., 2010 [18 ] EF ≥ 45% Janssens et al., 2006 [2 ]
204
184 219.2 4.7 4.2 4.2 4.2*** Schächinger et al., 2006 REPAIR-AMI [8 ] Lunde et al., 2006 ASTAMI [3 ] Grajek et al., 2010 [5 ] PCI ≥ 6 (hours) EF < 45% Meluzín et al., 2008 [16 ]
58
38 128.8 6.0 7.1 8.6 6.9 Plewka et al., 2009 [12 ] EF ≥ 45% Wollert et al., 2004 BOOST [6 ]
104
85 3684.5** 6.0 8.2 7.5 9.0 Chen et al., 2004 [9 ] Ge et al., 2006 TCT-STAMI [10 ] Traverse et al., 2010 [19 ] Long term PCI < 6 (hours) EF < 45% Piepoli et al., 2010 [18 ]
19
19 418 12 4.1 4.4 4.0 EF ≥ 45% Beitnes et al., 2009 ASTAMI [21 ]
81
64 198.9 28.6 4.0 3.7 5.6*** Grajek et al., 2010 [5 ] PCI ≥ 6 (hours) EF < 45% Meluzín et al., 2008 [16 ]
20
20 100 12 7.2 9.2 6.8 EF ≥ 45% Meyer et al., 2006 BOOST [20 ]
118
125 709.5 38 9.4 8.7 5.9 Yousef et al., 2009 BALANCE [22 ] Assmus et al., 2010 REPAIR-AMI CMR-Subs [23 ]
Weighted means.
**There was no stated mean value in Chen et al., 2004 [9 ]. A rough mean value of
was taken for weighted means.
***Grajek et al., 2010 [5 ]. SC delivery time of 5 was used.(b) Subgroups
Trial Patient number
Baseline LVEF* (percent)
Post-PCI LVEF (percent)
Baseline
LVESV (mL/m²)
Post-PCI
LVESV (mL/m2 ) BMSC Placebo BMSC Placebo BMSC Placebo BMSC Placebo BMSC Placebo
Short term PCI < 6 (hours) EF < 45% Penicka et al., 2007 +++++ [17 ]
113
69
37.2
38.6
41.5
40.4
90.7
85.7
89.3
91.1 Tendera et al., 2009 REGENT [4 ] Piepoli et al., 2010 [18 ] EF ≥ 45% Janssens et al., 2006 [2 ]
204
184
50.1
48.8
53.1
51.3
69.6
75.1
68.8
77.1 Schächinger et al., 2006 REPAIR-AMI [8 ] Lunde et al., 2006 ASTAMI [3 ] Grajek et al., 2010 [5 ] PCI ≥ 6 (hours) EF < 45% Meluzín et al., 2008 [16 ]
58
38
36.7
36.7
45
39.1
100
96
95
105 Plewka et al., 2009 [12 ] EF ≥ 45% Wollert et al., 2004 BOOST [6 ]
104
85
49.8
50.4
59.8
53.9
46
40
39
38 Chen et al., 2004 [9 ] Ge et al., 2006 TCT-STAMI [10 ] Traverse et al., 2010 [19 ] Long term PCI < 6 (hours) EF < 45% Piepoli et al., 2010 [18 ]
19
19
36.6
37.5
46.1
41
80.1
76.5
67.6
76 EF ≥ 45% Beitnes et al., 2009 ASTAMI [21 ]
81
64
53.1
52.9
51.9
52.8
73
75.8
78.1
77.6 Grajek et al., 2010 [5 ] PCI ≥ 6 (hours) EF < 45% Meluzín et al., 2008 [16 ]
20
20
40
40
47
40
100
96
97
113 EF ≥ 45% Meyer et al., 2006 BOOST [20 ]
118
125
49.8
50.4
55.1
47.8
75.3
73.7
71.7
93.8 Yousef et al., 2009 BALANCE [22 ] Assmus et al., 2010 REPAIR-AMI CMR-Subs [23 ]
Weighted means.